Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

39
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
39
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic common and rare variant association testing in 392,030 whole genomes in <i>All of Us</i>.

medRxiv : the preprint server for health sciences·2026
Same author

Multi-scale data improves performance of machine learning model for long COVID identification.

Communications medicine·2026
Same author

Downward bias in the association between APOE and Alzheimer's disease using prevalent and by-proxy disease sampling in the All of Us research program.

BMC medical genomics·2026
Same author

Genetic Prediction of Circulating Lipoprotein(a) Levels in Diverse Populations.

medRxiv : the preprint server for health sciences·2026
Same author

11 million days of longitudinal wearable data reveal novel future health insights.

medRxiv : the preprint server for health sciences·2026
Same author

A one-shot, lossless algorithm for cross-cohort learning in mixed-outcomes analysis.

Patterns (New York, N.Y.)·2025
Same journal

Sensitivity Analyses of a Scoring System for a Contraception Decision Aid.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Improving electronic health record processing of large language models via retrieval-augmented generation: A case study on dietary supplements.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Developing a User-Centered Mobile Application Prototype: Bridging Lower-Limb Fracture Care from Skilled Nursing Facility and Back to the Community.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

KERAP: A Knowledge-Enhanced Reasoning Approach for Accurate Zero-shot Diagnosis Prediction Using Multi-agent LLMs.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Automating Adjudication of Cardiovascular Events Using Large Language Models.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Predictive Factors and State-Level Barriers to Postpartum Birth Control Usage in the United States: Insights from PRAMS Phase 8.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K

A natural language processing algorithm to define a venous thromboembolism phenotype.

Eugenia R McPeek Hinz1, Lisa Bastarache2, Joshua C Denny3

  • 1Department of Pediatrics Duke University Medical Center, Durham NC.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|February 20, 2014
PubMed
Summary
This summary is machine-generated.

A novel Natural Language Processing (NLP) algorithm effectively identifies deep venous thrombosis and pulmonary embolism cases in electronic health records. This method enhances the capture of both acute and historical venous thromboembolic disease (VTE) occurrences.

More Related Videos

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

392
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K

Related Experiment Videos

Last Updated: May 2, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K
Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

392
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K

Area of Science:

  • Medical Informatics
  • Clinical Research
  • Health Data Science

Background:

  • Deep venous thrombosis (DVT) and pulmonary embolism (PE) contribute significantly to patient morbidity and mortality.
  • Identified risk factors account for only a small proportion of venous thromboembolic disease (VTE) cases.
  • Unidentified genetic factors are presumed to play a role in the remaining VTE cases.

Purpose of the Study:

  • To develop and validate a general-purpose Natural Language Processing (NLP) algorithm for retrospective VTE case identification.
  • To assess the algorithm's effectiveness in capturing both acute and historical VTE cases from de-identified electronic health records (EHRs).

Main Methods:

  • A Natural Language Processing (NLP) algorithm was designed to extract VTE cases from EHRs.
  • The algorithm was applied to training and separate evaluation datasets to determine its performance metrics.
  • Performance was evaluated using positive predictive value (PPV), sensitivity, and F-measure.
  • Specific strategies, including analysis of problem lists without VTE ICD-9 codes, were tested for capturing historical cases.

Main Results:

  • The NLP algorithm demonstrated high performance in the evaluation set with a positive predictive value (PPV) of 84.7% and sensitivity of 95.3% (F-measure 0.897).
  • Performance on the training set was comparable, with an F-measure of 0.925.
  • Utilizing the algorithm on problem lists for patients without VTE ICD-9 codes proved most effective for identifying historical VTE cases, achieving a PPV of 83%.

Conclusions:

  • The developed NLP algorithm offers an effective approach for capturing both acute and historical cases of venous thromboembolic disease (VTE).
  • Combining NLP analysis of VTE ICD-9 codes with non-ICD-9 problem lists enhances the comprehensive identification of VTE.
  • This methodology holds promise for improving VTE surveillance and research using EHR data.